Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncel, LLC is a specialized technical consultancy and contract research organization (CRO) that integrates materials science, nanotechnology, biomedical sciences, and biotechnology. Founded by Dr. Sema Oncel and Dr. Nuri Oncel, the company offers expertise in experimental design, functional nanomaterials design, laboratory protocol optimization, and the development of in vitro and in vivo models. Additionally, Oncel provides consulting on lab-on-a-chip devices, microfluidic platforms, and nanoscale sensor technologies. The company's leadership has a strong background in biomedical research, particularly in the development of small-molecule focal adhesion kinase (FAK) activators for gastrointestinal mucosal healing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncel.